ロード中...
The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation
OBJECTIVE: Accumulating epidemiological studies have demonstrated that diabetes is an important risk factor for dementia. However, the underlying pathological and molecular mechanisms, and effective treatment, have not been fully elucidated. Herein, we investigated the effect of the dipeptidyl pepti...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006898/ https://ncbi.nlm.nih.gov/pubmed/32032367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0228750 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|